معرفی
Oh Jeong-mi is a Professor in the Department of Pharmacy, College of Pharmacy, Seoul National University, and concurrently holds a Professorship at Seoul National University Hospital since 2005. Her 20-year academic career at SNU progressed from Assistant Professor (2004-2007) to Associate Professor (2007-2012) and full Professor (2012-present), with additional leadership roles including Chairman of the Practical Training Committee for the Korean Council for Pharmaceutical Education (2010-2012).
Education:
- B.S. from University of Texas at Austin
- Pharm.D. from University of Maryland at Baltimore
Professor Oh's research centers on clinical and translational pharmacy with three interconnected pillars: (1) pharmacogenomics of drug transporters and metabolic enzymes in organ transplantation, (2) age- and disease-specific drug safety and appropriateness, and (3) chemotherapy optimization through pharmacokinetic modeling. Her work bridges genomic science with clinical practice to enable personalized immunosuppressant therapy, particularly for kidney and liver transplant recipients.
Analysis of her 15 most recent publications reveals dominant research trajectories in CYP3A5/ABCB1 polymorphism impacts on tacrolimus/cyclosporine pharmacokinetics, with strong emphasis on Korean population-specific responses. Key subfields include pharmacometric modeling, transplant immunology, and genetic biomarker validation, consistently targeting clinical implementation of precision dosing protocols.
Scientific Awards:
- Howol Songam Next-Generation Academic Award (2022)
She has mentored 11 graduate students in pharmacogenomic applications for transplantation and oncology, with thesis topics spanning population pharmacokinetics, genetic association studies, and multidisciplinary team care models. Her research is conducted through the Clinical Pharmacy Laboratory, which employs collaborative frameworks involving clinicians, geneticists, and pharmacometricians to address complex drug therapy challenges in high-risk patient populations.
The laboratory maintains active partnerships with Seoul National University Hospital's transplant and oncology units, focusing on real-world implementation of pharmacogenomic-guided dosing protocols while investigating novel drug-drug interaction mechanisms in polypharmacy scenarios common among elderly and multi-morbid patients.
